Cancer Patient Support Call Center: A Program to Inform and Involve Newly Diagnosed Cancer Patients in Their Treatment Decisions by Johnson, David
  
 
 
 
 
 
 
 
 
 
 
 
 
Cancer Patient Support 
Call Center 
A Program to Inform and Involve Newly 
Diagnosed Cancer Patients in Their Treatment 
Decisions  
 
David Johnson 
A Master‟s Paper submitted to the faculty of the University 
of North Carolina at Chapel Hill in partial fulfillment of the 
requirements for the degree of Master of Public Heath in 
the Public Health Leadership Program. 
Chapel Hill 
2010 
 
 
 
1
st
 Reader: Dr. Diane Calleson 
3
rd
 Reader: Pamela Dickens 
2
nd
 Reader: Dr. Jeff Belkora 
Date Signed 
Date Signed 
Date Signed 
2 
 
 
Table of Contents 
 
I.   Introduction…………………………………………………………………………….3 
a. Background and Rationale…………………………………………………….....4 
 
II.   Literature Review…………..………………………………………………………….9 
a. Introduction………………………………………………………………………9 
b. Search Strategy…………………………………………………………………..10 
c. Summary & Analysis of Systematic Reviews…………………………………...11 
d. Summary & Analysis of Program Description and Evaluation………………….18 
e. Conclusion……………………………………………………………………….21 
 
III.  Program Plan………….………………………………………………………………22 
a. Program Overview……………………………………………………………….22 
b. Program Context………………………………………………………………....23 
c. Program Theory………………………………………………………………….27 
d. Goals and Objectives…………………………………………………………….31 
e. Implementation Plan……………………………………………………………..33 
f. Sustainability……………………………………………………………………..37 
g. Logic Model……………………………………………………………………...40 
 
IV.   Evaluation Plan…………..……………………………………………………………41 
a. Introduction and Rationale.……………………………………………………...41 
b. Study Design and Methods………………………………………………………45 
c. Dissemination Plan………………………………………………………………48 
d. Evaluation Questions…………………………………………………………….49 
 
V.   Discussion…...…………………………………………………………………………54 
 
VI.   Acknowledgements……...…………………………………………………………….56 
 
VII.  References…………………………………………………………………………..…56 
3 
 
 
I. Introduction 
 
 The philosophy of health care has recently shifted away from paternalistic care towards 
empowering patients to become increasingly informed and involved in their medical decision-
making.
1, 2 
  Despite theoretical support from health care agencies and professional organizations, 
achieving informed, shared decision-making (SDM) between patient and provider is extremely 
challenging in the current health care system.  Numerous barriers exist that prevent providers 
from engaging in this practice, and inhibit patients‟ ability to successfully become informed and 
involved in medical decision-making.
3 
   
 With these challenges come opportunities for novel, innovative programs to encourage, 
incentivize, and facilitate the steps needed for successful SDM between an informed, involved 
patient, and an accommodating provider.
4-6 
  Programs that perpetuate SDM on both the 
systematic delivery of health care, as well as the interpersonal level are essential.  
 The purpose of this Master‟s Paper is to plan the organization, implementation, delivery, 
and evaluation of a program, the Cancer Patient Support Call Center (PSCC), that improves the 
treatment decision-making process between patients newly diagnosed with cancer and their 
treating physicians.  In collaboration with faculty at the University of North Carolina at Chapel 
Hill Gillings School of Global Public Health and Dr. Jeff Belkora, at the University of 
California, San Francisco, we will explore the shortcomings of the current decision-making 
process that inhibit successful SDM in cancer care and review the literature for interventions that 
address these shortcomings.  We will also assess the rationale, context, and relevant theories for 
designing and implementing an effective, adoptable, and sustainable program.  The goals, 
objectives of our program will be explicitly stated, and the activities needed to reach these goals 
and objectives will be outlined.  Finally, we will design a plan for evaluating the extent to which 
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our goals and objectives are being reached while simultaneously developing strategies for 
modifying the organization and delivery of our interventions to improve the reach, effectiveness, 
adoption, and maintenance of our program. 
 
Background & Rationale 
Existing Data:  Significant research has been done to identify the major shortcomings in cancer 
management decision-making that hinder patients from making a fully informed decision.   
Firstly, patients attempt to collect information about their disease and treatment options 
from numerous outside sources prior to consultations with their physician in order to better 
understand their situation and alleviate anxiety.
7 
  Despite the vast amount of information 
available through media, Internet and print sources, much of this is of low quality, inaccurate, or 
out of date, and patients struggle to find concise, understandable, and relevant information.
8 
  Not 
surprisingly, prior research has shown that information acquisition is the most common unmet 
need mentioned by cancer patients.
9, 10 
  In order to become informed participants in the decision-
making process, patients need better access to high quality information resources outside of the 
physician encounter.   
Secondly, patients frequently do not have the opportunity to consider their personal 
preferences regarding treatment options or are unable to effectively communicate them during 
the consultation.
11 
  It is essential that physicians solicit patient priorities and treatment 
preferences because physician and patient often differ in their beliefs about disease
12 
 and goals 
of treatment.
13 
  This patient-centered approach to preference-sensitive decision-making 
acknowledges that,  
“Patients have many priorities in addition to maintaining their health, such as making a 
living, caring for family, and engaging in leisure activities, and these life activities 
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frequently involve trade-offs between health, comfort, relationships, and financial well-
being”.14 (pg. 1806) 
 
Even if given the opportunity, patients often struggle to convey personal concerns and remember 
important questions during the consultation, often due to distress and anxiety.
5 
  As a result, 
physicians are typically incapable of serving as the perfect decision-making agent for patients 
and interventions that help physicians become aware of their patients‟ personal preferences and 
encourage patient participation in the treatment decision are absolutely necessary.
15 
   
Thirdly, patients must become involved in the decision-making process to the maximum 
extent that they feel comfortable.  It has been well-studied that cancer patients generally prefer a 
greater level of involvement in the treatment decision-making process than they currently 
experience,
16
 and that patients who feel more involved in this process have a greater sustained 
level of satisfaction with their decision.
17 
  However, patients‟ desired level of involvement in the 
treatment decision is often variable, unpredictable, and depends on disease severity and level of 
disability.
18
  Therefore, the physician must “…avoid predicting their patients‟ role preference 
and start providing patients with an open communication climate that allows them to achieve 
their desired level of participation during decision-making”16(pg. 6).  
Lastly, patients are often overwhelmed with the amount of information discussed during 
a consultation.  Patients typically perceive physicians as the most valuable, credible, and 
influential source of information for treatment decision-making,
7 
 however they frequently 
struggle to understand the technical language used by physicians and have difficulty 
remembering what was discussed in the consultation.
19, 20 
  As a result, patients may leave 
consultations feeling confused, anxious, and uncertain about what decisions were made and how 
to proceed.
5 
  Interventions are needed to help patients record, organize, and recall the 
information discussed during the medical encounter for later reference.    
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Policy Frameworks 
Healthy People 2010
21 
 
Healthy People 2010 is a national disease prevention and health promotion initiative 
managed by the Office of Disease Prevention and Health Promotion and the US Department of 
Health and Human Services.  This report includes several priorities related to the patient-
centered approach to cancer care.  On a community level, this framework emphasizes that a 
healthy community enables people to maintain a high quality of life and productivity by offering 
access to health care services that focus on both treatment and prevention for all members of the 
community.  Healthy People 2010 “encourages local and State leaders to develop 
communitywide and statewide efforts that promote healthy behaviors, create healthy 
environments, and increase access to high-quality health care”.  
 Objective #1 of Health People 2010 is to “increase life expectancy and quality of life by 
helping individuals gain the knowledge, motivation, and opportunities they need to make 
informed decisions about their health”.  In addition, Cancer, Health Communication, and Public 
Health Infrastructure are 3 of the 28 focus areas specifically addressed by Healthy People. 
 
Institute of Medicine (IOM), 2001
22 
 
In the IOM report entitled “Crossing the Quality Chasm: A New Health System for the 
21
st
 Century”, patient-centeredness is defined as one of its six primary objectives for improving 
the quality of medical care in the 21
st
 century.  This report also indicates that the process of SDM 
reflects four of the ten “simple rules” for redesigning health care.  These rules include the 
customization of medical care based on patients‟ needs and values, allowing patients to be a 
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significant source of control, sharing knowledge and the free flow of information, and promoting 
evidence-based decision-making.  
 
National Cancer Institute 
 Two reports recently published by the National Cancer Institute (NCI) and the National 
Institutes of Health (NIH) emphasize the importance of patient-physician communication and 
SDM in improving health outcomes and satisfaction for cancer patients.
23, 24 
  The Outcomes 
Research Branch (ORB) of the NCI has indicated in its strategic plan that research assessing the 
delivery and impact of patient-centered communication throughout all aspects of cancer care is a 
key priority, and “encourages the development of innovative measurement approaches and study 
designs to help monitor and track the success of communication efforts over the course of the 
patient, family, and healthcare provider experience”.25     
 
General Health Policy Model (GHPM) - Outcomes Model for Assessing Quality of Health Care 
 Dr. Robert M. Kaplan, Professor and Chair of Family and Preventative Medicine at the 
University of California, San Diego (UCSD), and his colleagues began developing a General 
Health Policy Model (GHPM) in the 1970‟s, which emphasizes the importance of evaluating 
quality of health care in terms of improvements in quality of life in addition to simply extending 
life expectancy.  The “outcomes model”, as it is referred to, incorporates quality of life 
considerations by separating health status into distinct components, including life expectancy 
(mortality), functioning and symptoms (morbidity), preference for observed functional states 
(utility), and duration of stay in health state (prognosis).
26 
  This outcomes model considers the 
impact of care from the patient‟s perspective and encourages a process of SDM between a well-
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informed patient and an accommodating provider.  The communication of medical uncertainty, 
including the disclosure of probabilities of benefits and harms of treatments, and the solicitation 
of patient preferences for outcomes is paramount in this model of care.
1 
  
Kaplan argues that shifting our view of what constitutes successful medical care and 
adopting this outcomes-based conceptualization of health status may influence national health 
policy by placing the objectives of health care into a different focus, including how health 
indicator are described, outcomes are measured, clinical decisions are made, and resources are 
allocated.
26 
 
 
Informed Consent Policy Framework 
All states have standards for what constitutes valid informed consent.  Half of states rely 
on physician-based standards, which “require physicians to inform a patient of the risks, benefits, 
and alternatives to a treatment in the same manner that a „reasonably prudent practitioner‟ in the 
field would”, while the remaining states use patient-based standards which “hold physicians 
responsible for providing patients with all the information on risks, benefits, and alternatives to a 
treatment that a „reasonable patient‟ would attach significance to in a treatment decision”.27 (pg. 
430)  According to King and Moulton (2006), “given the current move in US health policy 
toward increased consumer responsibility in funding medical treatments, considering whether 
patients receive sufficient information and decision support to enable them to meaningfully 
participate in their health care is more imperative than ever”.27 (pg. 431) 
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II. Literature Review 
Introduction 
The goal of this review is to systematically examine the literature for evidence pertaining 
to interventions that promote and facilitate informed, SDM for patients facing cancer treatment 
decisions.  The shared approach to decision-making has gained widespread acceptance as the 
optimal strategy for making decisions on many aspects of cancer care and is increasingly viewed 
as an essential component of informed consent for undergoing treatment.
27, 28 
  The SDM process 
promotes informed choices because the physician must fully disclose potential risk and benefits 
for all possible treatment options and the patient is given the opportunity to share relevant 
personal information that may affect how they value certain outcomes and side effects of the 
treatment options.
29 
  Together, the physician, patient, and any other family members, friends, or 
relatives participating in the decision-making process integrate scientific knowledge about 
treatment efficacy with patient preferences for outcomes and potential side effects to make an 
informed choice on the best course of treatment.
1 
    
In order for SDM to successfully result in informed decisions, the patient must obtain 
accurate, valid and complete information about potential risks and benefits of all treatment 
options, adequately understand the tradeoffs for each of these options, and have sufficient 
opportunity to consider his or her individual preferences in relation to the treatment options and 
communicate these preferences to the physician.  Despite widespread acceptance of the SDM 
concept, numerous challenges and practical obstacles preclude the widespread adoption of 
interventions and the implementation of programs that promote this process.  It is necessary to 
systematically review the literature for evidence of successful interventions and programmatic 
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strategies in order to help design an effective, adoptable, sustainable program plan to improve the 
quality of decision-making for cancer patients facing difficult treatment decisions.    
 
Search Strategy 
 We conduct a search of PubMed/MEDLINE for meta-analyses, reviews, and evaluation 
studies using different combinations of the following MeSH terms: “Decision support 
techniques”, “decision-making”, “patient education”, “patient participation”, “neoplasms”, “tape 
recording”, “information dissemination”, “health attitudes, knowledge, practice”.  We then scan 
titles of results from related combinations of MeSH terms and major topics for relevance to 
interventions promoting informed, SDM.  Interventions addressing all types of medical decisions 
are evaluated for relevance, but particular attention is paid to interventions and programs 
involving cancer patients.   
 A search of meta-analyses and reviews containing “decision support techniques”, “patient 
education”, and “patient participation” MeSH terms produces 57 results, including 3 editions of a 
Cochrane Systematic Review on the role of decision aids in medical decision-making.  16 results 
are produced by a search of meta-analyses and reviews containing the MeSH terms “information 
dissemination”, and “patient participation”.  Of these results, 1 Cochrane Systematic Review 
examines interventions before consultations for helping patients address information needs.  
Among the 29 meta-analyses and reviews containing the MeSH terms “tape recording” and 
“neoplasms”, we identify 3 editions of a Cochrane Systematic Review on the use of consultation 
recording or summarizing.  3 additional smaller reviews examining the use of audio recording 
and other techniques for improving patient recall of medical information during oncology 
consultations are produced by this search. 
11 
 
 
  A search of evaluation studies under the major MeSH topic “neoplasms” that contains 
the MeSH term “decision-making” produces 73 results.  Only one citation appears to be an 
evaluation of a program that integrates all three interventions examined by the aforementioned 
Cochrane Reviews.  The reference sections of these evaluations are scanned for additional 
sources, and cross-referenced with the bibliographies of the previously identified Cochrane 
Reviews. 
 
Summary and Analysis of Systematic Reviews:     
 A critical appraisal of the three systematic reviews and one program evaluation study is 
necessary to assess the quality of evidence about the effectiveness of interventions to help 
patients become informed and involved in the treatment decision-making process.  We will 
summarize the background and study criteria, outcome measures, study methods, outcome 
results, and analyze each study individually.   
 
O‟Connor et al (2009) – Decision aids for people facing health treatment or screening decisions30  
 Background and Study Criteria: This Cochrane Systematic Review seeks to evaluate the 
efficacy of decision aids for people facing difficult, “close call” decisions that require weighing 
benefits, harms, and scientific uncertainty.  This review systematically evaluates published 
randomized controlled trials (RCTs).  The RCTs included in this review are studies of 
interventions designed to aid in patients‟ decision-making by providing information about 
treatment or screening options and their associated outcomes, as compared to no intervention, 
usual care, and alternate interventions.  A decision aid is defined by this review as an 
intervention that, at a minimum, provides information on the options and potential outcomes 
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relevant to a person‟s health status, and implicit methods to clarify values in order to help people 
make a particular choice.  Studies are included only if they involve subjects making actual 
decisions about either screening or treatment for themselves, for a child, or for an incapacitated 
significant other.  Included studies necessarily demonstrate that the intervention meet the 
minimum criteria to qualify as a patient decision aid as outlined by the International Patient 
Decision Aids Standards (IPDAS).
31 
  Studies are excluded from the review if they focus on 
decisions regarding lifestyle changes, entry into clinical trials, general advance directive 
decisions, education programs not geared to a specific decision, or interventions designed to 
improve adherence to or elicit informed consent regarding a recommended option.   
 Outcome Measures: This systematic review measures a broad range of outcomes.  
Primary outcomes include “attributes of the decision” – evidence that the patient decision aids 
improves how well the chosen decision matches the features that matter most to the informed 
patient (including knowledge, accurate risk perceptions, and value congruence with chosen 
option), and “attributes of the decision process” – evidence that the decision aids help patients 
recognize that a decision needs to be made, know the options, understand that values affect the 
decision and be clear about the features of each option that matter most, discuss these values 
with the physician, and become involved in the preferred way.  Other primary outcomes 
measured are decision making process variables including decisional conflict, patient-
practitioner communication, participation in decision-making, and satisfaction.  Secondary 
outcomes include behavior (proportion that remained undecided, which option was selected, and 
adherence to chosen option), health outcomes (health status and quality-of-life, anxiety, 
depression, emotional distress, regret, and confidence), and healthcare system factors 
(satisfaction, cost/cost effectiveness, consultation length, and litigation rates). 
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 Methods: The Cochrane Review method for identifying studies involves a thorough 
search of the major electronic databases, including MEDLINE, Cochrane Central Register of 
Controlled Trials, CINAHL, EMBASE, and PsycINFO.  Search strategies are published in the 
appendix of the review.  Two independent authors scan the titles and abstracts to determine 
relevance of the study.     
 Search Results: Of a total of 22,778 citations from the electronic database search, only 
1,293 citations focus on people‟s decision making, and 130 of these appear to be evaluations of 
interventions.  64 of these studies do not meet inclusion criteria, and the 66 remaining citations 
provide data on 55 trials which meet the inclusion criteria for the review.   
 Summary of Key Outcome Results:  This review provides substantial evidence that 
decision aids significantly improve patients‟ knowledge of their condition, options, and 
probabilities of outcomes, reduce decisional conflict, enhance patient-provider communication, 
and result in greater satisfaction with the decision and the decision-making process.     
Analysis:  The results of this review must be interpreted with caution.  First of all, the 
quality ratings of the RCTs included in this review universally suffer from lack of blinding.  In 
addition, the wide variety of contexts for decision-making and the broad array of outcomes 
measures yield insufficient power for finding differences in many interventions, outcomes, and 
subgroups.   Most importantly, only 7 of the 55 trials involve interventions for treatment of 
cancer (prostate = 2, breast = 5), and 11 study decision aids for cancer screening (prostate = 8, 
colon = 3), which greatly limits the applicability of these results to interventions to inform and 
involve patients with cancer facing treatment decisions.   
Taking these limitations into consideration, a Cochrane Systematic Review is arguably 
the most methodologically sound strategy for assessing multiple studies of an intervention, even 
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if such heterogeneity exists.  This review provides considerable evidence that decision aids 
provide patients with the intended benefit of improving knowledge and understanding, as well as 
improving various other patient-centered outcomes, even if a lack of external validity limits our 
confidence in extrapolating these findings to cancer treatment decisions. 
 
Kinnersley (2009) – Interventions before consultations for helping patients address their 
information needs
32 
  
 Background and Study Criteria:  This systematic review examines the effects on patients, 
providers, and health care systems of pre-consultation interventions designed to help patients 
address their information needs during consultations.  This review includes only RCTs that enroll 
patients before “one-on-one” consultations with a health care provider to compare usual care 
with interventions that directly addressed their information needs.  These interventions include 
encouraging the patient to identify and ask questions, express the amount of information they 
require, consider how they might express their information needs, overcome barriers to 
communication, and/or check their understanding of information provided during the 
consultation. 
 Outcome Measures:  Outcomes are divided in to three major categories, including the 
consultation process, the consultation outcome, and service outcomes.  Within these domains, the 
most commonly measured outcomes are: question asking, patient participation, patient anxiety, 
knowledge, satisfaction, and consultation length. 
 Methods: A thorough electronic search of MEDLINE, Cochrane Central Register of 
Controlled Trials, EMBASE, PsychINFO, ERIC, CINAHL databases is conducted to obtain 
sources for this review.  All search strategies are published in the appendix of this report.  Two 
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independent authors examine titles and abstracts for relevance.  In addition, the authors examine 
reference lists for further potentially-relevant citations, and contact authors of included studies 
for information regarding similar unpublished studies.  Finally, the authors hand-search the 
journal Patient Education and Counseling for additional studies since it contains the highest 
proportion of possibly-included studies in publication.     
 Search Results: 4876 citations are generated from the above-listed search strategy, and 71 
citations are identified by review authors for possible inclusion.  Additional citations are added 
from other reviews, additional reading and citations of reviewed articles, and hand searching of 
Patient Education and Counseling to create a final set of 106 citations to be assessed.  71 of 
these are excluded after the authors browse the articles for relevance, which leaves 35 papers 
describing 33 studies.  The total number of patients randomized in these 33 studies is 8,244.   
 Summary of Key Outcome Results:  Meta-analysis of study results show small but 
statistically significant increases in question-asking and patient satisfaction in patients receiving 
interventions compared to usual care.  Despite not being statistically significant, patient anxiety 
is substantially decreased both before and after consultations in the intervention group.   
Analysis:  While a systematic review is generally accepted as the most thorough and 
robust method for arriving at conclusions about the effect of an intervention, caution must be 
taken in interpreting results of this review due to the lack of sufficient information provided in 
the methods of some of the reports.  Despite this potential short-coming, a large body of research 
is reviewed, all of the studies are RCTs, and general consistency in the results is found across all 
studies.  The increase in question asking is the most significant, direct, and quantifiable effect of 
interventions before consultations intending to help patients address their information needs.  
Effects on other outcome measures such as anxiety, patient participation, and knowledge are 
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more difficult to ascertain due to the variability in assessment and measurement methods used by 
the studies.  As compared to the aforementioned systematic review on decision aids, a larger 
proportion of the studies (9 of 33) evaluate interventions in the Oncology setting.  The findings 
of this review should be considered substantial evidence of the benefit to the patient of pre-
consultation interventions that help patients address their information needs.   
 
Pitkethly (2009) – Recordings or summaries of consultations for people with cancer20  
 Background and Study Criteria:  This review evaluates the effects of interventions that 
help patients with cancer and their family members remember what was discussed during a 
consultation.  Randomized and quasi-randomized controlled trials of both adults and children 
diagnosed with cancer (and their families) are included in the review.  Studies are excluded that 
do not specifically address patients with cancer or are not controlled trials.  The review includes 
studies that evaluate the effects of audio and/or video recording of the consultation and written 
summaries of the key points of the consultation.   
 Outcome measures:  This review assesses the effect on information access, use, and 
understanding (information obtained, recalled, and level of understanding), the health care 
experience (satisfaction, participation in subsequent consultations, complaints and litigation), and 
health and well-being (physical and psychosocial health status).   
 Methods:  The studies included in this review were initially searched for in 1999 and 
subsequently updated in 2003, 2005, 2007 and 2009.  The strategy for obtaining sources used in 
the 2009 version of the review involve a systematic search tailored to each of the following 
electronic databases: MEDLINE, The Cochrane Library, CINAHL, Dissertation Abstracts, Index 
to Theses, EMBASE, PsychINFO, AMED, British Nursing Index, SCI-EXPANDED, SSCI, and 
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Sociological Abstracts.  The full search strategy is published in the appendix of the review.  Two 
authors independently assess the relevance of titles, abstracts, and full reports, check 
bibliographies of selected studies, and contact experts in the field. 
 Results:  37 potentially relevant studies are produced by the search strategy and 
considered for inclusion.  21 studies either do not specifically address patients with cancer or are 
not controlled trials and are therefore excluded after examination of the full text.  16 studies 
(reported in 24 papers) involving 2,318 participants are included in the final review.  15 of these 
studies are RCTs, and 1 was a quasi-randomised (sequential) controlled trial.           
 Summary of Outcome Results:  Overall, the majority of participants and their family 
members found the recordings or summaries of their consultation to be valuable.  In the 12 
studies that assess utilization of the intervention, between 60% and 100% of participants 
listened/watched the recording or read the summary at least once after the consultation.  The 
recordings or summaries were used to help inform between 41.5% and 94.4% of family and 
friends assessed in 9 studies.  The majority of studies (5 out of 9) find that patients who received 
a recording or summary reported better recall of the information discussed in their consultation.  
While no studies find a statistically significant difference between intervention and control 
groups in terms of anxiety or depression, 3 studies out of 10 demonstrate a greater level of 
satisfaction with the consultations among those receiving a recording or summary of the 
consultation.   
 Analysis:  While several limitations and potential biases exist, this systematic review 
provides the most robust assessment of the effects of these interventions for helping cancer 
patients understand and recall what was discussed during a consultation.  Biases of the included 
studies may have occurred in the recruitment of the study participants, the method of 
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randomization used, lack of blinding of clinicians and outcome assessors and varying levels of 
patient awareness of the study.  Despite these potential biases, which likely shift the results away 
from the null, the interventions are generally comparable across all studies, and all subjects are 
participating in a cancer care consultation which strengthens the applicability of the outcome 
results.  This review provides substantial evidence of the benefits of recording or summarizing 
consultations for cancer patients in terms of information recall after the consultation. 
 
Summary and Analysis of Program Description and Evaluation: 
Belkora 2008 – Monitoring the implementation of Consultation Planning, Recording, and 
Summarizing in a breast care center
6 
 
Goals and Objectives:  The Consultation Planning, Recording, and Summarizing (CPRS) 
program pilots the integration of the three interventions addressed in the above mentioned 
Cochrane Reviews into a high volume breast cancer clinic at the University of California, San 
Francisco (UCSF).  The goal of this program is to make newly diagnosed breast cancer patients 
as informed and involved in the decisions made during their treatment consultation as they want 
to be.  To our knowledge, this is the only program published in the literature that integrates the 
three decision support interventions (information gathering, question-listing, and consultation 
recording/summarizing) discussed in the aforementioned Cochrane Reviews into a clinical 
setting. 
The objectives of this program are to improve decision quality from a patient standpoint 
(decision self-efficacy, decisional conflict) while also evaluating the implementation of the 
program to figure out how to improve its reach, efficiency, and convenience for patients, 
physicians, and program staff. 
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Activities:  Within the context of an existing high volume breast care center, 8 schedulers 
were trained to connect women diagnosed breast cancer patients who are scheduled to see a 
treatment specialist with 1 of 14 trained pre-medical student interns to provide a fully integrated 
decision support service in conjunction with their usual treatment consultation over the period of 
March 1, 2005 and December 31, 2006.  These interns provide the patients with information 
relevant to their particular diagnosis via decision aids, then meet in person with the patients to 
complete a question-listing SCOPED note
33 
 prior to their treatment consultation.  Interns type up 
and print out these question lists and provide a copy to both the patient and the physician for 
reference during the consultation.  Interns accompany the patients in the physician encounter, 
making a digital recording and summarizing the key points of the consultation which they then 
provide to the patient after the appointment.   
A convenience sample of patients received a questionnaire soliciting measures of 
decisional self-efficacy (DSE) and decisional conflict scales (DCS) before and after the 
interventions to evaluate effectiveness of the interventions.   
Interviews and focus groups of physician, student interns, and scheduling staff were 
conducted to evaluate acceptability and find out ways in which the program could be modified to 
increase volume and improve convenience of intervention delivery, and improve utilization of 
resources.   
Analysis:  The evaluation strategy of this program combines both qualitative and 
quantitative measures that examine effectiveness of program interventions from a patient 
standpoint, as well as service delivery measures by program staff, interns, and physicians.  
Overall, only 38 out of the 278 patients (13%) who received program interventions were 
approached to complete DSE and DCS surveys due to logistical challenges.  All but one of these 
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women completed the surveys before and after the intervention, indicating that this method of 
evaluating patient-centered measures is feasible and agreeable to patients.  Despite the small 
proportion of women surveyed, results from the convenience sample convincingly showed 
significant improvement in DSE and a substantial decrease in DSC following the intervention.  
Evaluators concluded that this sample provided sufficient evidence of the effectiveness of the 
interventions. 
Qualitative analysis from interviews allowed physicians to express their overall opinion 
about the CPRS program, ways to improve service delivery logistics, and suggested 
modifications to question lists and summaries in order to make them more usable for both 
physician and patient.  Interviews of CPRS schedulers helped confirm patients‟ generally 
positive response to being offered an accompanying service.  They also contributed to changes in 
how potential program participants were identified and contacted, thereby improving the 
utilization of schedulers‟ time.  Finally, CPRS interns expressed satisfaction with the program 
and the experience of working closely with patients to help improve decision making, but 
suggested improvements in the flow of service delivery that would increase efficiency and 
improve time utilization.   
This study confirms the patient-centered benefits and effectiveness of interventions 
delivered by the CPRS program and help direct continued quality improvement of the program.  
As a result, the program is fully integrated in to the workflow of the breast care center as an 
accompanying service offered to newly diagnosed breast cancer patients in a manner that is 
acceptable to clinic staff, program staff, physicians and patients.  While the interventions and 
subsequent evaluation is limited to breast cancer patients at a breast cancer center, the study 
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results and program framework suggest a high level of adaptability to various other forms of 
cancer, particularly prostate cancer, in a variety of care settings.
5 
   
 
Conclusion 
 Three systematic reviews evaluating the merits of decision aids, pre-consultation 
interventions, and consultation recording/summarizing provide high quality evidence that these 
interventions improve the process of SDM by helping patients become more informed and 
involved in the decision-making process.  On the other hand, evidence of quantifiable benefit to 
the patient in terms of decreasing anxiety and depression is lacking.  This likely is due to 
challenges in measuring such subjective outcomes, and the substantial variability in personality 
type and coping ability among people with the same condition who are exposed to the same 
interventions.  Despite various limitations that call the internal validity of these reviews into 
question, Cochrane Systematic Reviews are generally considered on par with the highest level of 
evidence available.  While none of these reviews specifically or exclusively focus on 
interventions for cancer treatment decisions, all the reviews do address cancer decision-making 
to a varying degree.   
 The CPRS program provides substantial evidence that putting these evidence-based 
interventions into practice by integrating them into the flow of a high volume cancer care clinic 
is feasible and effective.  This evaluation is strengthened by a mixed-methods evaluation strategy 
that incorporates quantitative measures of effectiveness with qualitative data concerning 
logistics, workflow, and ways to improve service delivery. 
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III. Program Plan 
Program Overview 
The Patient Support Call Center (PSCC) program is a decision support service intended 
to help people newly diagnosed with early stage breast or prostate cancer become as informed 
and involved as they want to be while making treatment decisions with their doctors.  While 
these patients are dealing with the shock, fear, and stress of their diagnosis, they also face a 
series of very difficult and often overwhelming treatment decisions.  Our decision support 
intervention is ideally suited for patients with these particular cancers because no one treatment 
strategy has been proven to be clearly superior to the rest for all patients.
34, 35 
  As a result, a large 
number of acceptable treatment alternatives are available with a wide range of associated 
outcomes, and these patients face a highly preference-sensitive decision on how to proceed with 
the management of their disease. 
 Our program will utilize trained nursing students to administer 3 evidence-based decision 
support interventions including information gathering, question listing, and consultation 
recording/summarizing.
20, 30, 32 
  The interventions will be delivered to program recipients over 
the telephone and a secure online portal will be used to share information.  These interventions 
serve to better inform the recipient of their situation, prepare them to optimally address their 
information needs and personal preferences during the consultation, and improve their ability to 
recall information after the consultation.  
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Program Context 
Political Environment   
The political environment is conducive to the implementation of interventions that help 
inform and involve patients in the decision-making process regarding their cancer care, as these 
interventions are aligned with current local, state, and national priorities previously discussed.  
Legal and governmental policy organizations, academics, and governing bodies of the medical 
profession have generally supported the shift from paternalism to informed choice in medical 
decision making.  Support is especially strong in situations where benefits are ambiguous and 
adverse outcomes are variable, as in decisions to undergo screening and treatment for cancer.
36, 37 
   
In fact, in May 2007, the state of Washington formally endorsed the practice of SDM by 
passing legislation that encourages collaborative efforts to develop, certify, use, and evaluate 
tools and programs that help inform and involve the patient in medical discussions.
38 
  Several 
more states are considering similar legislation that mandates pilot SDM projects, and federal 
legislation is under consideration in Congress which proposes similar experimental programs 
within Medicare.
39 
   
Respected medical organizations including the IOM, American College of Physicians (ACP), 
the United States Preventative Services Task Force (USPSTF), the NCI, and the American 
Society of Clinical Oncology (ASCO), strongly endorse the practice of fully informing patients 
about all potential benefits and harms of all treatment options, and allowing the patient and 
physician to jointly choose the course of action that best suits the patients‟ personal preferences. 
While the theory of informed, SDM is broadly supported by clinicians, resistance to its 
practice on the individual practitioner level still exists.  For numerous reasons, including time 
constraints, lack of familiarity and training, reimbursement disincentives, perceived patient 
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preferences and lack of motivation, physicians often fail to implement this method of decision 
making in practice.
3, 40, 41 
  However, these barriers are not insurmountable, and effective, 
organized interventions that support and enhance physicians‟ current practice are not likely to be 
controversial.   
 
Health System Factors   
The PSCC program will be introduced in the context of the existing framework of cancer 
management within a high volume oncology organization (HVOO), and will be framed as an 
intervention that improves the quality of the decision-making process by informing and 
involving the patient to a greater degree.  As opposed to restructuring the current structure of 
cancer care delivery, this intervention will be an optional service which supplements the existing 
patient-provider relationship and enhances the patients‟ ability to navigate through complicated 
cancer management decisions with their physician.    
 Within the HVOO system, participating physicians must be supportive of the PSCC 
program and encourage patients to take advantage of the interventions.  PSCC trainees must be 
dedicated to connecting with eligible patients, and the trainees must champion the program by 
skillfully, professionally, and compassionately executing the interventions.     
 
Financial Resources   
Incorporating the PSCC program in to the existing infrastructure and resources of the 
HVOO will allow for substantial cost savings and efficiencies, especially in the realm of human 
resources and facility costs.   
25 
 
 
 Financial compensation will be necessary for staff members involved in training the 
PSCC trainees.  Funding will be necessary to cover the cost of training materials and intervention 
supplies, such as a conference calling and recording service, and software for referring eligible 
patients, sharing HIPAA-protected information, and record-keeping.  Web-based portals exist 
(Microsoft Healthvault) for securely sharing medical records, question lists, consultation 
recordings and summaries among trainees, patients, and providers.  Finally, marketing materials 
for recruiting trainees and raising physician and patient awareness of the program will necessary.  
 
Funding agency criteria   
Potential funding will come from philanthropic donations by social venture capitalists, 
Medicare and Medicaid funds, grants from other governmental agencies, CSC funds, and private 
insurance companies.  Funding agencies must show a willingness to make a long term 
commitment to sustaining the CIN program.   
 
Technical/Administrative Feasibility   
Dr. Belkora and his staff have substantial experience in decision support service training 
through their work with the Breast Care Center at UCSF.  Key to the administrative feasibility of 
this program is successfully creating business associate agreements (BAA) between the PSCC 
organization and both the trainee source and the HVOO to automate the referral process and 
seamlessly share information between PSCC trainees, patients, and providers.   
The technical feasibility will hinge on the ease of use of the web-based medical 
information storage program and the referral system.  PSCC trainees must be able to share the 
question lists, audio recordings, and consultations summaries with the patient and the physician 
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in order for the interventions to be effective.  The use of 3
rd
 party “language lines” to translate 
medical encounters into different languages is widespread in hospitals, outpatient clinics, and 
community health centers, which suggests that audio recording of the treatment consultation 
through a telephone is technically feasible.  Numerous companies offer web-based recording and 
digital storage of telephone conversations.   
 
Timeframe   
The timeframe for implementing the pilot phase of the PSCC program at 3 initial HVOO 
clinics is approximately 1 year.  In the first 6 months, we must establish the PSCC organization 
as an independently functioning entity, identify a source of PSCC trainees, and create BAAs with 
the trainee source and the participating HVOO.  Technical and administrative feasibility will be 
addressed by the end of the year.  The upfront training of PSCC trainees will need to be complete 
within the year in order to begin offering the service to patients.  Finally, the PSCC organization 
must identify and secure funding sources to allow the implementation of the pilot phase of the 
program. 
 
Stakeholders and Collaborators  
In order to create a sustainable, effective, widespread program for improving informed 
decision-making, a coalition of organizations and agencies with similar goals must be formed, 
and the intervention must benefit all members of the coalition to a certain extent. 
 First and foremost, physicians and patients must be willing to incorporate this model of 
decision-making into the traditional patient-provider dyad.  In addition, participating 
organizations, such as the HVOO, must support the administration and promote the utilization of 
27 
 
 
the PSCC program.  Finally, policymakers and medical organizations must come together to 
endorse this type of intervention, both by showing public support and providing financial 
assistance.   
 
Challenges   
We expect the PSCC program to face numerous challenges during its implementation, 
uptake, and maintenance.  Securing sufficient, long term funding is certainly a significant 
concern.  Convincing physicians to participate in an intervention that some may feel 
compromises their sense of autonomy and traditional way of practice may become problematic. 
Physicians may not initially be comfortable with an outside party recording the consultation via a 
conference call.    However, these interventions have been generally well received by physicians 
in other settings, and an effort to help physicians understand the potential benefits to the patient 
will likely alleviate these concerns.   
 
 Program Theory 
In planning the PSCC program, we utilize the ecological perspective of program theory, 
which emphasizes the interaction between, and interdependence of, factors from multiple levels 
of a health problem.
42, 43 
  We consider factors that exert influence on the 
intrapersonal/individual, interpersonal, and community levels, and apply them to the PRECEDE-
PROCEED planning model
44 
 for identifying intervention strategies to address these factors.   
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Intrapersonal/Individual Level   
Health-Belief Model (HBM) concepts, including perceived susceptibility, perceived 
severity, perceived benefits, cues to action, and self-efficacy, are employed to understand the 
individual characteristics that might influence a patient‟s readiness to become informed and 
involved in the decision-making process.  Planning the delivery of PSCC interventions must take 
into account how susceptible newly diagnosed cancer patients believe they are to making 
uninformed, uninvolved treatment decisions, and the perceived severity of the health outcomes 
resulting from these decisions.  Participants must also believe that the interventions will increase 
their chance of becoming involved and informed, and be confident in their ability to effectively 
utilize the interventions offered by the PSCC program.  As we plan this program, we must realize 
that patients need explicit cues to activate their participation in informed, SDM, and may face 
substantial psychological barriers to adopting the program‟s intervention such as stress, anxiety, 
and emotional instability.        
 The target population of the PSCC program will likely be at various stages of acting as 
identified by the Precaution Adoption Process Model (PAPM).  Many patients will be unaware 
that they have the option of being an active participant in their treatment decision (Stage 1), 
while others may be aware of this role but not engage in actions to become informed and 
involved due to lack of self-efficacy and/or psychological barriers (Stage 2).  On the other hand, 
patients may have already decided that they want to take an active role in their treatment decision 
(Stage 5), and will benefit from the PSCC interventions by gaining the ability to act on this 
intention (Stage 6) and maintain their involvement in management decisions throughout the 
course of their illness (Stage 7).  PSCC trainees need to be trained to recognize which stage each 
patient is in and tailor their interaction accordingly.   
29 
 
 
Interpersonal Level   
The approach that newly-diagnosed cancer patients take towards making treatment 
decisions is influenced by social interactions with family members, friends, and health care 
providers, and environmental factors that include past experiences with illness, and their 
exposure to health information - concepts which are recognized by the Social-Cognitive Theory 
(SCT).  A one-on-one interaction between the patient and the trainee will maximize patients‟ 
behavioral capability and self-efficacy by arming them with the knowledge and skills necessary 
to actively participate in the decision-making process in a well-informed manner.  By 
specifically addressing the patients‟ questions, issues, and personal preferences and allowing the 
patient to become involved in the decision-making process, the consulting physician will not 
only further facilitate behavior capability and self-efficacy, but also fulfill the patients‟ 
expectations of the PSCC program interventions and provide positive reinforcement of the 
patient‟s participation in the interventions.  A forum for patients to share and incorporate past 
experiences with illness, both their own and those of friends and family members, into the 
treatment discussion is essential to account for the interpersonal and environmental influences 
likely to affect how involved and informed a patient becomes in their treatment decision.  The 
SCT asserts that patients observe the experience of others and model their expectations after 
these experiences.  If a growing number of newly diagnosed cancer patients are able to become 
active participants in well-informed, well-considered treatment decisions through the PSCC 
program, other cancer patients who are facing management decisions will come to expect this 
type of decision-making experience.   
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Community Level   
The “community” in the PSCC program context consist of patients, family and friends of 
patients, health care providers, and PSCC organization staff members who share the common 
interest of helping newly diagnosed cancer patients become as informed and involved in their 
treatment decision as they want.     
 The Organizational Change Stage Theory is used to conceptualize the stages that an 
organization must pass through in order to institute lasting change.  The first stage is to define 
the problem.  The HVOO organization must recognize that patients are not always able to 
become as informed and involved in their treatment decision as they want to be on their own.  
Both patients and cancer care providers must acknowledge that patients would benefit from 
being better informed about their illness, their treatment options, and possible outcomes prior to 
their consultation.  They must also acknowledge that involving patients to a greater extent by 
soliciting their personal preferences is necessary to arrive at the best possible treatment decision.  
The affiliated providers move in to the second stage of change by adopting the PSCC program, 
allocating resources to begin implementation, and formulating policies and directives to guide 
implementation.  The third stage of organizational change is full implementation of the program 
by providers and PSCC staff.  Over the long term, the program is institutionalized as it becomes 
entrenched in the HVOO culture at sites all over the United States and emerges as a standard 
decision support practice provided by the organization and its affiliated providers and expected 
by the cancer patient community. 
 We utilize the Diffusion Theory of Innovations to plan how the uptake of the PSCC 
interventions will disseminate throughout the HVOO organization and the cancer community as 
a whole.  The PSCC interventions necessarily offer a relative advantage to current practices of 
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informing and involving patients in treatment decisions.  PSCC interventions will be simple 
enough to allow widespread understanding and utilization.  PSCC trainees personalize the 
interventions in order to make them compatible with every individual in any population of newly 
diagnosed cancer patients.  The “trialability” of the PSCC program is exemplified by plans to 
initially pilot the program at 3 HVOO sites in order to demonstrate the “observability” of 
intervention results before widespread adoption to other sites. 
 
 
Goals and Objectives 
 
Program Goal  
The goal of the PSCC program is to help people with cancer be as informed and involved 
as they want to be while making treatment decisions with their doctors.  Objectives were defined 
with the help of Dr. Jeffery Belkora, Ph.D. (telephone conversation, Feb. 5, 2010) 
 
Program Objectives  
We will use the “RE-AIM” format to organize program objectives in to categories 
including program reach, effectiveness, adoption, implementation, and maintenance.
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Reach:  
 Trainees 
o By Aug. 2010, agreement will be made with trainee source to supply trainees for a 
period of at least 1 year at a time. 
o By Jan. 2011, PSCC staff (Dr. Jeff Belkora) will train 10 low-cost trainees to 
deliver PSCC interventions.  
 Referral pipeline 
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o By Jan. 2011, 3 HVOO-affiliated clinics will serve as referral centers to PSCC.  
 Patients 
o By Jan. 2011, a total of at least 5 new patients per week will be enrolled in the 
PSCC program. 
Effectiveness: 
 By Aug. 2011, PSCC recipients will report an average pre-consultation Decision Self-
Efficacy (DSE) score of at least 3 (on a validated 5 point scale). 
 By Aug. 2011, PSCC recipients will report an average score of 2.5 or lower (out of 5) on 
the validated Decisional Conflict Scale (DCS). 
 By Aug. 2011, PSCC recipients will report a satisfaction level with their consultation of 
at least 8, on a 10-point scale. 
Adoption: 
 Patients 
o By Jan. 2011, PSCC trainees will succeed in making contact with 50% of the 
potential recipients they attempt to call by phone. 
o By Jan. 2011, 50% of those patients reached by PSCC trainees will be enrolled in 
the PSCC program. 
 Trainees 
o By Aug. 2011, 75% of PSCC trainees will be enrolling and delivering PSCC 
interventions to at least 1 patient per week on average. 
o By Jan. 2012, 100% of PSCC trainees will receive ongoing training and 
supervision during their first year.    
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o By Jan. 2014, 90% of PSCC trainees will remain in this role for at least 1 year at a 
time. 
Implementation: 
 Fidelity of Intervention 
o By Jan. 2012, 90% of actual SCOPED notes (question listing intervention) 
created by trainees will be highly comparable to expert SCOPED notes created 
from audio recordings of question-listing sessions.  
o By Aug. 2011, 95% of completed question lists will be available to the patient 
online prior to the date of the consultation.  
o By Aug. 2011, 95% of audio recordings and consultations summaries will be 
available to patient online within 1 week of the consultation 
Maintenance:  
 By Jan. 2012, a sustainable source of financing will be in place (ie. 3rd party payor) 
 By Aug. 2013, 100% of BAA agreements with trainee sources & HVOO clinics will be 
renewed each year 
 By Jan. 2012, the number of PSCC trainees and number of new patients enrolled each 
week will triple to 30 trainees and at least 15 new patients. 
 
Implementation Plan 
 
 In order to successfully implement our program, we need to carefully plan how to 
structure our organization and deliver our services.  This plan was developed with the help of Dr. 
Jeffery Belkora, Ph.D. (telephone conversation, Feb. 13, 2010). 
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Organizational Plan   
The implementation of the organizational plan requires resources and inputs from 
numerous sources.  [NEW ENTITY - (Name TBD)] will be founded as an independent 
organization and managed by a full time program director with the ability to establish working 
relationships with HVOO administration and cancer care providers, professional training 
organizations (nursing schools), and 3
rd
 party payers (Medicare/Medicaid, insurance companies).  
The program director will oversee the implementation and delivery of the program, handle 
financial and legal issues, and ensure the sustainability and future growth of the program.   
NEW ENTITY will enter into a Business Associate Agreement (BAA) with HVOO that 
permits the referral of patients to NEW ENTITY, allows sharing of protected health information 
(PHI), including medical records and contact information of patients with a new diagnosis of 
early prostate or breast cancer, and contains a contract for reimbursing NEW ENTITY for PSCC 
services.  NEW ENTITY will also establish an agreement with the professional training 
organization (nursing school) which provides NEW ENTITY with a source of nursing 
students/service learners who will receive training in the delivery of PSCC decision-support 
interventions by Dr. Jeff Belkora of the University of California, San Francisco.  In return, 
trainees will gain professional experience with one-on-one patient interactions, and learn 
valuable skills and techniques to assist patients in making informed, involved decision making.  
Nursing student trainees will work with NEW ENTITY on a volunteer basis or for course and/or 
practicum credit in agreement with their nursing school.  Dr. Belkora and staff will administer 
both upfront and ongoing training for nurse trainees through online modules, videos, and case 
reports.   
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The BAA will facilitate the automatic referral of newly diagnosed prostate and breast 
cancer patients to NEW ENTITY.  Patients who are contacted by trainees and agree to become 
recipients of PSCC program interventions will gain access to a secure, web-based portal for 
storing personal health information (e.g. Microsoft HealthVault).  Through this portal, the trainee 
can obtain the patient‟s medical records pertaining to their cancer diagnosis to tailor information 
gathering and connect the patient with information resources, as well as share outputs of the 
interventions with the patient (pre-consultation question list, audio recording and summary of the 
consultation).   
 
Service Utilization Plan   
Once the organizational plan has been implemented, the automatic referral system is in 
place, and the web-based medical information portal is functioning, the service utilization plan 
will come into effect.   
In the initial stages of PSCC program implementation, we intend to utilize 3 HVOO-
affiliated clinics to administer our intervention.  From these 3 clinics, our target number of newly 
diagnosed prostate cancer or breast cancer patients that become PSCC program recipients is 5 
per week.  Assuming that the decision support interventions take a total of 6-8 hours per 
recipient and one trainee can provide the interventions to one recipient per week, a minimum of 
5 trainees are initially needed.  To account for potential problems synchronizing trainee and 
recipient schedules, we will employ twice the minimum number of necessary trainees to ensure 
that the program reaches 5 new recipients per week.  Therefore, we will initially recruit and train 
10 nursing student trainees for the pilot phase of our program.     
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HVOO providers and/or schedulers will identify appropriate when making appointments 
for treatment consultations for PSCC trainees to contact.  Schedulers will provide potential 
recipients with information via email, pamphlet, and/or website about the PSCC program, and a 
handbook containing information regarding their disease, treatment options, and frequently asked 
questions.  PSCC trainees will then contact these potential recipients via telephone to offer PSCC 
services.  If the patient agrees to become a recipient, the PSCC will create an individual account 
on the web-based medical information portal (ie. Microsoft HealthVault).  At the patient‟s 
convenience, the trainee will administer a validated Decision Self-Efficacy (DSE) survey, 
provide the patient with additional resources for information pertaining to their specific 
condition, and administer the question-listing intervention using the SCOPED note format.
33 
  
The PSCC trainee will make the question list available on the web-based portal prior to the 
consultation.  They will also email a copy to the patient and/or HVOO for use during the 
consultation. 
PSCC trainees will discuss with the recipient how best to record the consultation.  Using 
the speakerphone function on either the recipient‟s personal cell phone or a NEW ENTITY-
provided cell phone, the trainee will be dialed in to the consultation.  This consultation will be 
recorded by a conference call recording service (AT&T, Conference-plus, Recordmycalls.com), 
converted into a digital file, and posted on the web-based portal for the patient to access.  The 
trainee will use the recording to summarize the key points of the consultation, specifically 
addressing the questions and issues elicited in the pre-consultation question listing session. 
PSCC trainees will make a follow up phone call to the recipient within one week to 
ensure that they successfully received all the intended interventions, administer a validated 
Decisional Conflict Scale (DCS) survey, and ascertain where the patient is in the decision-
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making process.  This marks the closure of one service unit cycle.  At this point, the service 
cycle will either be permanently closed if the patient has made a treatment decision or reopened 
if the patient has another treatment consultation scheduled and would like to continue to receive 
the PSCC interventions.   
 
Sustainability 
 
In the long term, we envision the PSCC model becoming institutionalized as an integral 
service of the cancer care system.  We hope that the cancer community will come to view this 
type of intervention as the standard of care for supporting decision-making, cancer patients will 
come to expect this type of service, and physicians will continue to effectively incorporate these 
decision-making strategies in the appropriate situations. 
 The challenge for our program beyond the implementation stage will be to maintain the 
support of cancer care organizations and their providers, expand the model to other arenas of 
cancer care, establish a stable source of PSCC trainees by integrating the provision of this service 
in to the nursing curriculum, and implement a sustainable financing scheme.   
By demonstrating to the participating HVOOs and providers that these patient-centered 
interventions improve the quality of decision-making in difficult, high-stakes situations, we hope 
to gain widespread acceptance within the HVOO network and the greater cancer care provider 
community.  Supportive physicians and leaders in the field of cancer decision-making who 
endorse and champion the PSCC program interventions are critical for the sustainability and 
expansion of our program into a variety of cancer care provider organizations, both community-
based and academic.  The key to expansion of our program is PSCC‟s model of a centralized, 
web-based referral and record maintenance system.  As an increasing number and variety of 
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organizations begin to participate in the program, the increased demand will be easily met by 
increasing the capacity of our web-based systems.  Growing personnel demands will 
simultaneously be met by increasing the number of trainees delivering the interventions.   
Nurse educators and PSCC trainees must realize the benefit of gaining the experience of 
helping patients handle a difficult and stressful period in their life.  Incorporating this type of 
learning experience into the nursing curriculum will contribute to establishing a continuous 
source of trainees for the PSCC program. 
To secure sustainable financing, third-party payers must be convinced of the benefits 
covering this service for their beneficiaries.  It will be necessary to enlist private insurance 
companies and public payers such as Medicare and Medicaid to help subsidize the cost of the 
PSCC program so that eventually, none of the extra cost of the decision-support services is borne 
by the recipient.  As national, state, and local policies continue to shift their emphasis towards 
more patient-centered decision-making practices, the interventions provided by the PSCC 
program will become increasingly relevant to this emerging cancer care ideology.  It is essential 
that our program capitalizes on this shift in order to gain support from financial, political, and 
medical institutions.        
 Throughout the first year of implementation, the program director will be charged with 
aligning patient demand with PSCC trainee supply to maximize the efficiency of human 
resources.  While it is important to reach as many patients as possible, excessive investment in 
trainees is a waste of both financial resources and trainees‟ time.  As the program‟s reach 
expands, the number of new trainees must grow appropriately to maintain efficiency.     
Prudent analysis of program evaluation information is essential to assess the 
effectiveness, feasibility, and agreeability of certain aspects of service delivery.  For example, it 
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may become clear that the benefits to the patients provided by the consultation recording 
intervention do not outweigh the logistical challenges and cost.  Therefore, as the program 
progresses, certain aspects of service delivery may be modified, emphasized, and/or omitted.  
These strategies will ensure the sustainability of the PSCC program in order to make lasting 
improvements in the decision-making process of cancer patients.
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 Logic Model 
Resources/Inputs: 
 
Human 
 Training staff (Dr. Belkora) 
 PSCC Trainees 
 HVOO Physicians 
 Program coordinator 
 Board of Directors or Professional 
Advisory Board 
 
Collaborating partners 
 Dr. Belkora (UCSF) – 
consultant/technical advisor 
 Trainee source 
 HVOO 
 
Financial 
 3rd party payer (ie. private 
insurance) 
 HVOO contributions 
 Philanthropic grants from social 
venture capitalists 
 Fee-for-service 
 
Material 
 Training materials 
 SCOPED note templates and 
software 
 Information sources/online 
resource kit (ie. cancer.gov) 
 Conference call recording service 
 Web-based referral and contact 
management system  
 Secure web-based information 
storage and access portal  
 
Oncology thought and practice leaders 
 Dr. Laura Esserman (UCSF) 
Activities:  
 
Train PSCC trainees  
 
Recruit HVOOs to participate in 
program 
 
Educate HVOO providers on PSCC 
program 
 
Providers/schedulers at HVOOs 
identify appropriate for enrollment, 
and inform them about program 
 
Trainees contact potential recipients 
via telephone and enroll in program 
 
Trainees administer pre-intervention 
decision self-efficacy (DSE) survey  
 
Trainees provide recipients with 
written and web-based materials with 
disease-specific information 
 
PSCC trainees help recipients create 
question list using the SCOPED note 
format prior to the consultation, 
which is made available to both 
recipient and physician online. 
 
Consultation is recorded using 
telephone and made available to 
trainee and patient online. 
 
Trainee uses recording to create 
document summarizing key points of 
consultation, answers to questions on 
question list, and other issues 
addressed in consultation, and makes 
available to recipient online. 
 
Trainee follows up with recipient 
about consultation, collects 
evaluation information, and 
administers decisional conflict scale 
(DCS) questionnaire. 
Outputs:  
 
Corps of nursing student 
trainees prepared to 
administer PSCC 
decision support services 
 
Stream of new patients 
from HVOOs referred to 
PSCC 
 
Targeted number of 
referred patients enroll in 
PSCC program 
 
Recipients receive 
information on their 
diagnosis from PSCC 
trainee 
 
Completed question 
available online prior to 
the date of the 
consultation.  
 
Audio recordings and 
summaries of 
consultation available 
online within 1 week of 
the consultation 
 
Post-consultation follow 
up interview with 
recipient  
 
Outcomes:  
 
PSCC recipients report an 
average DSE of over 3 (on 
validated 1-5 scale) 
 
PSCC recipients report an 
average DCS of under 2.5 
after their medical visit (on 
validated 1-5 scale) 
 
PSCC recipients report an 
average satisfaction level of 
[8] or above (on validated 
10 point scale) 
 
Impact: 
 
Newly diagnosed cancer patients are more 
informed about their diagnosis and treatment 
options at the time of their treatment 
consultation. 
 
Newly diagnosed cancer patients are more 
involved in their treatment decision 
consultation. 
 
Improved patient-provider communication 
during consultation. 
 
Greater alignment between patient 
preferences and treatment decision. 
 
Increased patient satisfaction with 
consultation and treatment decision. 
 
Increasing number of providers and HVOO 
clinics adopting PSCC program 
 
Physicians at HVOO incorporate PSCC 
interventions into daily practice 
 
Policy changes supporting use of decision-
support services 
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IV.  Evaluation Plan 
Introduction 
Program Overview & Rationale for Evaluation 
 While progress in modern medicine and advancements in the treatment of cancer have 
certainly led to improvements in disease survival and quality of life, the multitude of treatment 
options for diseases such as early breast and prostate cancer has inevitably become 
overwhelming for many patients as they struggle to weight the benefits and possible harms of 
these different options.  As a result, many patients with a new diagnosis of early breast or 
prostate cancer are not able to become informed, involved participants in their treatment 
decisions and subsequently are not able to effectively align their course management with 
personal preferences.  To address this public health issue, the PSCC will be implemented to 
provide patients at a HVOO with evidence-based interventions that improve the quality of 
decision-making.  These interventions include information gathering,
30 
 question listing,
32 
 and 
consultation recording/summarizing.
20 
 
 While these interventions are morally justified
32 
, grounded in a strong evidence base, and 
have been shown to be effective, feasible, and acceptable to cancer patients in a real clinical 
setting,
6 
 our program requires evaluation for several reasons.  First, our program delivery 
strategy, which utilizes a centralized call center model, is a novel approach to administering 
these interventions.  While successfully delivered in other settings, the complex fiscal, 
socioeconomic, demographic, interpersonal, and interorganizational context of our program 
provides a wealth of challenges and potential obstacles.  Evaluation will help us determine if our 
program is succeeding in overcoming these contextual challenges.  Second, since this method of 
service delivery is new and untested, a systematic evaluation will give us the opportunity for 
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ongoing quality improvement of the design and management of many aspects of program 
implementation and activities.  Third, evaluation will allow us to monitor our progress towards 
program goals and justify the continued support and utilization of our program to our funders, 
stakeholders, staff members, and participants.  If the program is not only feasible and acceptable 
to all parties involved, but also successful in achieving our goal of improved quality of decision-
making for patients, it will increase the potential for expansion of the program and widespread 
dissemination of these methods.
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Evaluator Role 
The role of the PSCC evaluator will be to engage stakeholders to actively participate in the 
evaluation, and manage all evaluation activities, which include planning and budgeting for the 
evaluation, developing evaluation objectives, addressing data collection issues, reporting 
findings, and working with stakeholders and collaborating evaluators.
46, 47 
  The ideal evaluation 
strategy is to form a team that is headed by an internal evaluator and supplemented by an 
external evaluator and stakeholder representation.
47 
  The internal evaluator brings an invested, 
participatory approach to the team while the external evaluator serves to maintain a professional 
distance from the program and program staff and provide fresh perspectives and insights to the 
evaluation.  Contributions from stakeholders are necessary to ensure the evaluation addresses the 
information that these parties are most interested in. 
 It is essential that the lead evaluator a strong foundation in the program theories that 
directed the development of our program plan.  He or she must also possess a firm understanding 
of the service delivery strategy and specific activities.  The most important individual 
characteristics of a successful evaluator are:
47 
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 Strong communication skills with all levels of personnel 
 Leadership, management, and organizational ability 
 Ability to remain flexible and problem solve as the evaluation progresses 
 Previous evaluation experience 
 Ability to work well with a wide variety of stakeholders, including training staff, nursing 
school administrators, trainees, HVOOs and their providers, and funding agencies 
 Understanding of the goals of evaluation and how it will be used 
 Ability to be objective, honest, and thorough in collection of data and reporting of 
findings 
 Familiarity in both qualitative and quantitative data collection and reporting 
 Technical ability to collect, maintain, and interpret process measures through automated 
web-based applications. 
 
Stakeholder Input 
 Key stakeholders of our program are those that increase the credibility of our evaluation, 
implement the key activities of the evaluation, advocate for changes to institutionalize the 
evaluation findings, and fund/authorize continuation and expansion of the program.
46 
  These 
include the HVOO and its cancer care providers, the nursing schools that provide trainees, the 
trainees who deliver the intervention, the training staff, funding agencies, potential 3
rd
 party 
payers, and program recipients.  Involving those stakeholders that are directly involved in 
delivering and receiving program services helps identify areas for improvement in the activities 
leading to program outputs.  Engaging those stakeholders who will use evaluation information to 
determine whether they will continue to fund, support, and participate in the program is 
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necessary to identify the information these stakeholders deem necessary to make these decisions.  
It will be beneficial to have stakeholder representatives on the evaluation team to help define 
questions and outline data collection and evaluation methods.  
 Questions that will be asked of stakeholders include:  What about this program is 
important to you?  What would you like this program to accomplish?  What questions to you see 
as critical to the evaluation?  How much progress do you expect this program to make?  How 
will you use the results of this evaluation?  What resources are you willing to contribute to the 
evaluation?
46 
 
 Conversely, stakeholders might be expected to ask: What is the duration of this program?  
What resources will I be expected to contribute to the evaluation?  How will my input be 
incorporated into the evaluation?  How will I be informed of evaluation results?   
 
Challenges 
 Constructing an evaluation that caters to the needs of all stakeholders is no simple task 
and we expect to encounter numerous challenges:  Justifying that each of the three interventions 
is necessary to achieve our goal of informing and involving patients; proving that our 
interventions are the cause of the changes in outcome measures, rather than other factors; 
engaging busy stakeholders (physicians) to participate in evaluation; measuring and reporting 
less-quantifiable impact objectives using Intrepretivism/Constructivism and Theory-based 
evaluation methods; and convincing funders that progress towards the desired impact may not be 
initially self-evident, but that a long term commitment to the evaluation is necessary.
47 
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Evaluation Study Design & Methods 
Design 
 While designing our evaluation plan, we took into account the need to evaluate both 
implementation/process measures, as well as effectiveness/outcome measures.  Our novel service 
delivery model will require ongoing process evaluation to determine whether or not our program 
has been implemented as planned – also known as “implementation fidelity”.  We will need 
continuous information regarding what activities are actually taking place, what is the reach of 
our program, and whether sufficient inputs been allocated and mobilized.
46 
  If actual 
performance falls short of planned performance, our evaluation must serve to explain the 
differences and suggest ways to make improvements.   
 The decision-support interventions included in our program have each been extensively 
researched and found to be effectiveness in improving the quality of the decision-making 
process.
20, 30, 32 
  In addition, the integration of these decision-support services into the clinical 
setting has been previously shown to be effective and agreeable to participants, staff members, 
and physicians.
6 
  Therefore, we feel that while determining a causal relationship between our 
intervention and patient-centered outcomes (decision self-efficacy, decisional conflict, and 
satisfaction with the consultation) is certainly ideal, it is not strictly necessary to justify the 
benefits of our program.  Rather, acceptance of the prolific evidence base and moral foundation 
on which our program is grounded is essential.  Consequently, we chose to focus of our 
evaluation more heavily on implementation, adoption, and acceptance rather than proving 
causality. 
 Given these considerations and the nature of our program, we will utilize a one group, 
pre-test/post-test evaluation design for the outcome/effectiveness measures of interest.  
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Collecting and analyzing data only from program participants is the most practical and efficient 
use of evaluator time and resources.  In addition, soliciting evaluation information from newly 
diagnosed cancer patients is already a delicate issue and would be excessively intrusive, 
insensitive, and unjustified in those patients who have not agreed to participate in our program.   
 For the implementation/process evaluation, the pre-experimental design is the least 
complicated and least expensive strategy that is still sufficient for outcome documentation.  Data 
will be collected continuously as the program is implemented, and participants are enrolled and 
receive the interventions.  The pre-experimental design allows us to compare data at various 
points in time to the pre-stated objective targets.
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Methods 
 Appropriate evaluation methods are necessary to meaningfully answer our evaluation 
questions.  The most effective way to address our wide variety of evaluation questions is to 
combine quantitative data with qualitative analysis that not only answers our pre-stated 
questions, but also provides us with information for ongoing modification and improvement of  
our program.   
 Quantitative data will be collected from several sources.  Successful achievement of our 
implementation objectives will be evaluated using training records, the business associates 
agreements (BAAs), and online enrollment records.  Reviewing our online record system where 
participants‟ medical records, questions lists, and audio recordings and consultations are stored 
will allow us to evaluate the extent to which our reach, adoption, implementation and 
maintenance objective targets are met.  To evaluate our effectiveness objectives, we will collect 
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data on decision self-efficacy (DSE) and decisional conflict (DSC) according to widely used, 
validated methods.
49 
 
 Qualitative measures will be utilized in our program evaluation in order to learn about the 
strengths and weaknesses of the implementation and execution of our program.  The extent to 
which our program is adopted and accepted by potential participants, program staff, cancer care 
providers, and 3
rd
 party payers is essential to our evaluation, and qualitative analysis is the most 
useful way to determine what is working and what needs to be improved to guide the future 
direction of our program.  The main strategy for collecting this information will be through focus 
groups and open-ended interviews.  Depending on what evaluation question is being asked, 
HVOO clinic administrators, cancer care providers, program staff, and participants will be 
involved in the focus groups and open-ended interviews.   
 Focus groups have the advantage of being cost and time efficient as they only require a 
small number of evaluator man-power to collect information from a large number of people.  
They have the advantage of promoting collaboration, brainstorming, and discussion between 
various stakeholders who have differing points of view.  Evaluators may therefore be more 
successful in collecting information leading to improvements which benefit a wide range of 
stakeholders.  On the other hand, focus groups may not be appropriate for certain outcome 
measures that involved revealing personal information to the group.  Focus groups, for the 
purpose of our evaluation, are most useful for process and implementation monitoring.
48 
 
 Individual open-ended interviews are less efficient, but often have a high response rate.  
Our interviews will be conducted over the phone to program participants, who are likely to be 
personally invested in the program interventions and will hopefully be willing to contribute their 
perspective and reflect on their experience to help improve the program.  The number of 
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individual, in-depth, open-ended interviews that can be conducted by our evaluators will be 
limited by time and money constraints.  Therefore, a convenience sample of patients will be 
taken among those who received the interventions as planned.  Additionally, it will be 
informative to interview those participants who did not successfully receive all planned 
interventions and investigate the shortcomings in our implementation that prevented full service 
delivery and complete fidelity to the program plan.   
 
Dissemination Plan 
 While our evaluation period does not have a distinct termination point, periodic reporting 
of evaluation results is necessary to monitor the progress of our program and reassure our 
stakeholders and funding agencies that the program is being carried out as intended.  After the 
first year of implementation, a formal written report will be submitted to key stakeholders, 
including the oncology clinic administrators, board members, and physicians, nursing school 
administrators, and funding agencies.  This report may include an executive summary outlining 
the structure and organization of our program, the background, rationale, and context of our 
program, utilization data, and key quantitative and qualitative outcomes. 
 Stakeholders will also be interested in ongoing efficiency and quality improvement 
efforts.  Biannual review of evaluation data, especially focus groups and in-depth interviews, will 
be compiled in order to guide these improvement efforts as the program expands its reach.  The 
ongoing quality improvements must be shared with program staff, nursing school administrators, 
referring physicians, and the oncology group administrators to ensure that modifications made to 
program organization and service delivery are understood and adopted by all participants.   
 Importantly, evaluation results must be shared with external groups that promote the 
process of informed, involved decision-making in cancer care.  We will report our methods and 
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patient-centered benefits of our program, using both quantitative and qualitative results, to 
national health organizations (National Cancer Institute, American Cancer Society, Institute of 
Medicine), policy advocacy groups, and other high volume oncology groups in both private and 
academic settings.  It will be prudent to draft manuscripts for publication in a wide range of 
journals, which may include, Patient Education and Counseling, Medical Decision Making, 
Journal of Clinical Oncology, Annals of Oncology, American Journal of Preventive Medicine, 
and Annals of Internal Medicine, among others.  We will seek out opportunities to present the 
key findings of our program at oncology meetings, forums on informed decision-making, and 
professional training organizations such as medical schools and nursing schools, in order to 
familiarize a wide range of both medical and non-medical personnel with the underlying 
concepts and program methods.  These activities are essential to further progress towards a more 
patient-centered approach to treatment decision-making in cancer care which allows patients to 
become as informed and involved as they want to be.   
 
Evaluation Questions: 
Objective 1 (Reach): By Jan. 2011, PSCC staff (Dr. Jeff Belkora) will train 10 low-cost Nursing 
student trainees to deliver question-listing support services  
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2011, are 10 low-cost Nursing 
student trainees actually trained to deliver 
question-listing support services by 
PSCC staff (Dr. Jeff Belkora)  
Nursing school educators/ 
administrators, training 
staff 
Review training logs 
What were the barriers that made training 
nursing students difficult? 
Nursing student trainees, 
training staff, nursing 
school educators/ 
administrators 
Focus groups, open-
ended interviews 
What aspects of the training process were 
effective and agreeable? 
Nursing student trainees, 
training staff, nursing 
school educators/ 
administrators 
Focus groups, open-
ended interviews 
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How can the training process be 
improved? 
 Nursing student trainees, 
training staff, nursing 
school aeducators/ 
dministrators 
Focus groups, open-
ended interviews 
Did trainees gain adequate knowledge 
from training process? 
Nursing student trainees Pre/post-tests of 
decision-making 
process knowledge 
 
Objective 2 (Reach): By Jan. 2011, 3 HVOO-affiliated clinics will serve as referral centers to 
PSCC program 
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2011, are 3 HVOO-affiliated 
clinics serving as referral centers to 
PSCC program? 
Program director, HVOO 
clinic administrators 
Review Business 
Associates Agreements 
(BAA) 
How were clinics successfully recruited 
to participate? 
Program director, HVOO 
clinic administrators 
Open-ended interviews 
What barriers prevented clinics from 
participating? 
Program director, HVOO 
clinic administrators 
Open-ended interviews 
How could barriers to participation be 
overcome? 
HVOO clinic 
administrators 
Open-ended interviews 
Where the interests of the HVOO-
affiliated clinics addressed when forming 
the partnership with PSCC? 
HCOV clinic 
administrators 
Open-ended interviews 
 
Objective 3 (Reach): By Jan. 2011, a total of at least 5 new patients per week will be enrolled in 
the PSCC program. 
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2011, are a total of at least 5 new 
patients enrolling in the PSCC program 
per week? 
Program director Review online 
enrollment records 
What factors prevent patients from 
enrolling in the program? 
Nursing student trainees, 
eligible patients who did 
not enroll 
Focus groups, open-
ended interviews 
What aspects of the enrollment process 
are successful? 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
How can enrollment process be 
improved? 
Nursing student trainees, 
program director, HVOO 
administrators,  
Open-ended interviews 
 
Objective 4 (Effectiveness): By Aug. 2011, PSCC recipients will report an average pre-
consultation Decision Self-Efficacy (DSE) score of at least 3 (on a validated 5 point scale), an 
average score of 2.5 or lower (out of 5) on the validated Decisional Conflict Scale (DCS) after 
the consultation, and a satisfaction level with their consultation of at least 8 (out of 10).*  
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Evaluation Questions Participant Evaluation Methods 
By Aug. 2011, will PSCC recipients 
report an average pre-consultation 
Decision Self-Efficacy (DSE) score of at 
least 3 (on a validated 5 point scale), an 
average score of 2.5 or lower (out of 5) 
on the validated Decisional Conflict 
Scale (DCS) after the consultation, a 
satisfaction level with their consultation 
of at least 8, on a 10-point scale. 
Nursing student trainees, 
participants 
Pre- and post-
consultation 
interviews/surveys 
- Validated DSE scale 
- Validated DCS 
measure 
 
Are there any logistical problems 
administering pre- and post-consultation 
interviews and surveys to participants? 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
Do patients have any personal objections  
or emotional barriers to answering the 
interview/survey questions?  If so, what 
are they? 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
How can the pre- and post-consultation 
interview/survey process be improved 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
*
Individual effectiveness objectives are combined into a single objective since evaluation 
questions, participants, and evaluation methods are the same for each individual objective 
 
Objective 5 (Adoption): By Jan. 2011, 50% of those patients reached by PSCC Nursing student 
trainees will be enrolled in the PSCC program 
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2011, are 50% of those patients 
reached by PSCC Nursing student 
trainees enrolled in the PSCC program 
Nursing student trainees Contact and enrollment 
logs 
What prevents patients from enrolling in 
the program? 
Nursing student trainees, 
non-participating patients 
Focus groups, open-
ended interviews 
What aspects of the enrollment process 
are successful? 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
How can enrollment process be improved 
to increase rate of enrollment? 
Nursing student trainees, 
participants 
Focus groups, open-
ended interviews 
 
Objective 6 (Adoption): By Aug. 2011, 75% of PSCC Nursing student trainees will be enrolling 
and delivering PSCC interventions to at least 1 patient per week on average. 
 
Evaluation Questions Participant Evaluation Methods 
By Aug. 2011, are at least 75% of PSCC 
Nursing student trainees enrolling and 
delivering PSCC interventions to average 
of at least 1 patient per week? 
Program director Enrollment and output 
logs 
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Is enrolling 1 patient per week an 
appropriate work load? 
Nursing student trainees, 
program director 
Focus groups, open-
ended interviews 
What barriers exist to enrolling at least 1 
patient per week?  
Nursing student trainees, 
program director 
Focus groups, open-
ended interviews 
How can barriers to enrollment be 
overcome so that each trainee can enroll 
at least 1 patient per week? 
Nursing student trainees, 
program director 
Focus groups, open-
ended interviews 
 
Objective 7 (Adoption): By Jan. 2014, 90% of PSCC Nursing student trainees will remain in 
this role for at least 1 year at a time. 
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2014, are 90% of PSCC Nursing 
student trainees remaining  in this role for 
at least 1 year at a time? 
Program director Review training and 
participation logs 
Why are Nursing student trainees unable 
to remain in this role for 1 year? 
Nursing student trainees, 
former  nursing student 
trainees, nursing school 
educators/administrators 
Focus groups, open-
ended interviews 
What support services could be offered to 
help Nursing student trainees remain in 
this role for 1 year? 
Nursing student trainees, 
program director, nursing 
school 
educators/administrators 
Focus groups, open-
ended interviews 
 
Objective 8 (Implementation): By Jan. 2012, 90% of actual SCOPED notes created by trainees 
will be highly comparable to expert SCOPED notes created from audio recordings of question-
listing sessions.  
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2012, are 90% of actual 
SCOPED notes created by trainees highly 
comparable to expert SCOPED notes 
created from audio recordings of 
question-listing sessions? 
Training staff Review of expert 
SCOPED notes and 
trainee-created 
SCOPED notes 
How do trainee-created SCOPED notes 
fall short of expert SCOPED notes? 
Training staff Review of expert 
SCOPED notes and 
trainee-created 
SCOPED notes 
How can trainee-created SCOPED notes 
be improved to more closely resemble 
expert SCOPED notes?  Can systematic 
deficiencies be identified and corrected 
by changes in training program? 
Training staff, program 
director 
Focus groups 
 
Objective 9 (Implementation): By Aug. 2011, 95% of completed question lists will be 
available to the patient online prior to the date of the consultation and 95% of audio recordings 
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and consultations summaries will be available to patient online within 1 week of the 
consultation. 
 
Evaluation Questions Participant Evaluation Methods 
By Aug. 2011, are 95% of completed 
question lists available to the patient 
online prior to the date of the 
consultation and are 95% of audio 
recordings and consultations summaries 
available to patient online within 1 week 
of the consultation? 
Program director Review participant files 
in online portal 
What barriers exist to making question 
lists and audio recording/summaries 
available on time? 
Nursing student trainees, 
program director 
Focus groups, open-
ended interviews 
What improvements can be made to 
make it easier for questions lists and 
audio recordings/summaries to be made 
available online in time? 
Nursing student trainees, 
program director 
Focus groups, open-
ended interviews 
 
Objective 10 (Maintanence): By Aug. 2013, 100% of BAA agreements with trainee sources & 
HVOO clinics will be renewed each year. 
 
Evaluation Questions Participant Evaluation Methods 
By Aug. 2013, were 100% of BAA 
agreements with trainee sources & 
HVOO clinics renewed each year? 
Program director Review BAA contracts 
What reasons did trainee sources (nursing 
schools) not renew the BAA and 
discontinue participating in the PSCC 
program? 
Nursing school 
administrators, program 
director 
Open-ended interviews 
What reasons did HVOO clinics not 
renew the BAA and discontinue 
participating in the PSCC program? 
HVOO administrators, 
program director 
Open-ended interviews 
How can PSCC program and BAAs be 
modified to ensure yearly renewal by all 
participating entities? 
Nursing school 
administrators, HVOO 
administrators, program 
director 
Focus groups, open-
ended interviews 
 
Objective 11 (Maintanence): By Jan. 2013, the number of PSCC trainees and number of new 
patients enrolled each week will triple to 30 trainees and at least 15 new patients. 
 
Evaluation Questions Participant Evaluation Methods 
By Jan. 2013, has the  number of PSCC 
trainees and number of new patients 
enrolled each week tripled to 30 trainees 
and at least 15 new patients? 
Program director Review training logs, 
review enrollment logs 
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What aspects of the program have 
allowed successful expansion in the 
number of trainees? 
Program director, nursing 
school administrators,  
Longitudinal surveys, 
open-ended interviews 
What aspects of the program have 
allowed successful expansion in the 
number of patients referred? 
Program director, HVOO 
clinic administrators 
Longitudinal surveys, 
open-ended interviews 
What factors have prevented the program 
from expanding?  How can these factors 
be overcome? 
Program director, nursing 
school administrators, 
HVOO clinic 
administrators 
Longitudinal surveys, 
open-ended interviews 
 
 
 
V. Discussion 
 The management of cancer and chronic disease requires patients and physicians to make 
complex, difficult, value-based decisions about the best strategy for treatment.  For disease such 
as early prostate and breast cancer, numerous treatment options exist with varying potential 
harms and benefits.
50 
  When no one treatment option is superior, the best treatment decision for 
each patient depends on their personal preferences. 
 While SDM has recently emerged as the recommended paradigm for addressing 
preference-sensitive decisions in disease management,
1, 14, 22, 27, 29 
 efforts to implement this 
strategy in practice have fallen short.
11, 16 
  Numerous barriers inhibit physicians from soliciting 
patient preferences, and patients are often not up to the challenge of becoming informed and 
involved in their treatment decision.
3, 41 
   
 However, several intervention strategies which promote SDM have been thoroughly 
researched, including information gathering/decision aids,
30 
 pre-consultation question listing,
32 
 
and consultation summarizing/recording.
20 
  Individually, these interventions have been shown to 
improve certain aspects of the decision-making process, and the integration of all three of  these 
interventions into the flow of a high volume breast cancer center has been successful.
6 
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 The goal of this Masters Paper is to plan a program that utilizes evidence-based and 
morally grounded interventions to improve the quality of treatment decisions made by newly 
diagnosed breast and prostate cancer patients and their physicians by empowering patients to 
become as informed and involved as they want to be in their treatment decision, and increasing 
physician awareness of the personal preferences of their patients.   
The long term goal for this program is to further encourage the culture of SDM in cancer 
care by disseminating these concepts and strategies to the wider cancer care community.  Our 
program utilizes an innovative service delivery strategy, which involves delivery of the decision-
support interventions by trainees via telephone.  This model has both advantages and 
disadvantages.  While it lacks the benefits of face-to-face personal contact, this strategy 
facilitates the efficient increase in program capacity in order to rapidly expand the reach of the 
program, both within the HVOO and in other health care settings.     
 On a personal level, I find the concepts and strategies laid forth by this program plan to 
be essential for high quality care.  In my future career as a Urologic Oncologist, I foresee a large 
part of my daily practice revolving around helping patients make the treatment decision that best 
suits their individual goals and preferences.  I believe that utilizing a decision-support program 
such as the one described in this paper will greatly enhance the experience of the patient, and 
ensure that as a physician, I am adequately soliciting patient preferences and that our ultimate 
treatment strategy aligns with those preferences.  Much is made in public health about 
overdiagnosis and overtreatment, particularly in cancer care.  While the debate about 
overdiagnosis of breast and prostate cancer by PSA screening and mammography, respectively, 
is likely to continue for some time, I believe that the most effective way to address the problem 
of overtreatment in cancer care is to work to better inform and involve the patient in the 
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treatment decision.  This program is only one strategy for improving the quality of decision-
making in cancer care and much work still needs to be done to ensure that all patients are 
afforded the opportunity to become as informed and involved as they want to be in the 
management of their disease.  
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